Abstract

Accumulating evidence have suggested that long noncoding RNAs (lncRNAs) are known to regulate diverse tumorigenic processes. Recently, a novel lncRNA LINC01939 was underexpressed and emerged as a tumor suppressive lncRNA in gastric cancer (GC). In this study, we aimed to investigate the biological function and molecular mechanism of LINC01939 in GC. We found that LINC01939 expression was significantly downregulated in GC tissues and cell lines. Low expression of LINC01939 was correlated with tumor metastasis and shorter survival in GC patients. Functionally, LINC01939 overexpression remarkably inhibited the invasion and migration of GC cells in vitro and in vivo. Mechanistically, LINC01939 regulated the expression of early growth response 2 (EGR2) protein by competitively binding to miR-17-5p. Upregulation of miR-17-5p reversed GC metastasis and EMT process caused by LINC01939 by rescue analysis. Taken together, these results suggested that LINC01939 repressed GC invasion and migration by functioning as a ceRNA for miR-17-5p to regulate EGR2 expression. Our findings provided a novel prognostic marker and therapeutic target for GC patients.

Details

Title
LINC01939 inhibits the metastasis of gastric cancer by acting as a molecular sponge of miR-17-5p to regulate EGR2 expression
Author
Chen, Mi 1 ; Li, Fan 1 ; Si-Min, Zhang 2 ; Li, Yong 3   VIAFID ORCID Logo  ; Chen, Peng 1 ; Peng, Xin 1 ; Dong-Bo, Liu 4 ; Ma, Charlie 5   VIAFID ORCID Logo  ; Wen-Jie, Zhang 6 ; Zhen-Wei, Zou 1 ; Pin-Dong, Li 1 

 Huazhong University of Science and Technology, Cancer Center, Union Hospital, Tongji Medical College, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223) 
 Huazhong University of Science and Technology, Department of Emergency, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223) 
 Hubei University of Medicine, Department of Oncology, Renmin Hospital, Shiyan, China (GRID:grid.443573.2) (ISNI:0000 0004 1799 2448) 
 Huazhong University of Science and Technology, Cancer Center, Tongji Hospital, Tongji Medical College, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223) 
 Fox Chase Cancer Center, Department of Radiation Oncology, Philadelphia, USA (GRID:grid.412530.1) (ISNI:0000 0004 0456 6466) 
 Shihezi University School of Medicine, Department of Pathology, Shihezi, China (GRID:grid.411680.a) (ISNI:0000 0001 0514 4044) 
Publication year
2019
Publication date
Jan 2019
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2171189068
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.